H. Lundbeck A/S operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other
pharmaceutical manufacturers in Europe:
sales of 19.65 billion Swedish Kronor [US$2.19 billion]
of which 62%
Stada Arzneimittel AG
(2.12 billion Euro [US$2.24 billion]
of which 58%
was Generics), and
based in France
(1.52 billion Euro [US$1.61 billion]
of which 73%
was Specialty Care).
H. Lundbeck A/S reported sales of 14.59 billion Danish Kroner (US$2.08 billion)
December of 2015.
increase of 8.4%
versus 2014, when the company's sales were 13.47 billion Danish Kroner.
Despite this increase, sales are still
below the level achieved in 2013, when H. Lundbeck A/S
reported sales of 15.26 billion Danish Kroner.
The sales level in 2015 was fairly close to the level five years ago: in 2010, H. Lundbeck A/S had sales
of 14.77 billion Danish Kroner.